China Antidiabetic Biguanides Market Research Report 2017

January 2017 | 107 pages | ID: C73E321499AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetic Biguanides

Revenue, means the sales value of Antidiabetic Biguanides

This report studies Antidiabetic Biguanides in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Anderson Hay & Grain Inc.
• Border Valley
• Sanofi
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Boehringer Ingelheim

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Metformin IR
• Metformin SR

Split by Application, this report focuses on consumption, market share and growth rate of Antidiabetic Biguanides in each application, can be divided into

• Hospital
• Clinic

Contents

China Antidiabetic Biguanides Market Research Report 2017

1 ANTIDIABETIC BIGUANIDES MARKET OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Biguanides
1.2 Antidiabetic Biguanides Segment by Type
  1.2.1 China Production Market Share of Antidiabetic Biguanides Type in 2015
  1.2.2 Metformin IR
  1.2.3 Metformin SR
1.3 Applications of Antidiabetic Biguanides
  1.3.1 Antidiabetic Biguanides Consumption Market Share by Application in 2015
  1.3.2 Hospital
  1.3.3 Clinic
1.4 China Market Size (Value) of Antidiabetic Biguanides (2011-2021)
1.5 China Antidiabetic Biguanides Status and Outlook
1.6 Government Policies

2 CHINA ANTIDIABETIC BIGUANIDES MARKET COMPETITION BY MANUFACTURERS

2.1 China Antidiabetic Biguanides Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Antidiabetic Biguanides Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Antidiabetic Biguanides Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Antidiabetic Biguanides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetic Biguanides Market Competitive Situation and Trends
  2.5.1 Antidiabetic Biguanides Market Concentration Rate
  2.5.2 Antidiabetic Biguanides Market Share of Top 3 and Top 5 Manufacturers

3 CHINA ANTIDIABETIC BIGUANIDES MANUFACTURERS PROFILES/ANALYSIS

3.1 Anderson Hay & Grain Inc.
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.1.2.1 Metformin IR
    3.1.2.2 Metformin SR
  3.1.3 Anderson Hay & Grain Inc. Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Border Valley
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.2.2.1 Metformin IR
    3.2.2.2 Metformin SR
  3.2.3 Border Valley 107 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Sanofi
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.3.2.1 Metformin IR
    3.3.2.2 Metformin SR
  3.3.3 Sanofi 120 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Takeda Pharmaceuticals
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.4.2.1 Metformin IR
    3.4.2.2 Metformin SR
  3.4.3 Takeda Pharmaceuticals Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Eli Lilly
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.5.2.1 Metformin IR
    3.5.2.2 Metformin SR
  3.5.3 Eli Lilly Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Merck & Co.
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.6.2.1 Metformin IR
    3.6.2.2 Metformin SR
  3.6.3 Merck & Co. Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Novo Nordisk
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.7.2.1 Metformin IR
    3.7.2.2 Metformin SR
  3.7.3 Novo Nordisk Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Bristol-Myers Squibb
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.8.2.1 Metformin IR
    3.8.2.2 Metformin SR
  3.8.3 Bristol-Myers Squibb Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Pfizer
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.9.2.1 Metformin IR
    3.9.2.2 Metformin SR
  3.9.3 Pfizer Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 AstraZeneca
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Antidiabetic Biguanides Product Type, Application and Specification
    3.10.2.1 Metformin IR
    3.10.2.2 Metformin SR
  3.10.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 GlaxoSmithKline
3.12 Boehringer Ingelheim

4 CHINA ANTIDIABETIC BIGUANIDES CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Antidiabetic Biguanides Capacity, Production and Growth (2011-2016)
4.2 China Antidiabetic Biguanides Revenue and Growth (2011-2016)
4.3 China Antidiabetic Biguanides Production, Consumption, Export and Import (2011-2016)

5 CHINA ANTIDIABETIC BIGUANIDES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Antidiabetic Biguanides Production and Market Share by Type (2011-2016)
5.2 China Antidiabetic Biguanides Revenue and Market Share by Type (2011-2016)
5.3 China Antidiabetic Biguanides Price by Type (2011-2016)
5.4 China Antidiabetic Biguanides Production Growth by Type (2011-2016)

6 CHINA ANTIDIABETIC BIGUANIDES MARKET ANALYSIS BY APPLICATION

6.1 China Antidiabetic Biguanides Consumption and Market Share by Application (2011-2016)
6.2 China Antidiabetic Biguanides Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINAANTIDIABETIC BIGUANIDES MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Antidiabetic Biguanides Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Antidiabetic Biguanides Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Antidiabetic Biguanides Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Antidiabetic Biguanides Sales Price by Regions (Provinces)(2011-2016)
7.2 China Antidiabetic Biguanides Consumption by Regions (Provinces)(2011-2016)
7.3 China Antidiabetic Biguanides Production, Consumption, Export and Import (2011-2016)

8 ANTIDIABETIC BIGUANIDES MANUFACTURING COST ANALYSIS

8.1 Antidiabetic Biguanides Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antidiabetic Biguanides

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antidiabetic Biguanides Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antidiabetic Biguanides Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA ANTIDIABETIC BIGUANIDES MARKET FORECAST (2016-2021)

12.1 China Antidiabetic Biguanides Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Antidiabetic Biguanides Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Antidiabetic Biguanides Production Forecast by Type (2016-2021)
12.4 China Antidiabetic Biguanides Consumption Forecast by Application (2016-2021)
12.5 China Antidiabetic Biguanides Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Antidiabetic Biguanides Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Antidiabetic Biguanides Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Antidiabetic Biguanides Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Antidiabetic Biguanides Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Biguanides
Figure China Production Market Share of Antidiabetic Biguanides by Type in 2015
Figure Product Picture of Metformin IR
Table Major Manufacturers of Metformin IR
Figure Product Picture of Metformin SR
Table Major Manufacturers of Metformin SR
Table Antidiabetic Biguanides Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Antidiabetic Biguanides Revenue (Million USD) and Growth Rate (2011-2021)
Table China Antidiabetic Biguanides Capacity of Key Manufacturers (2015 and 2016)
Table China Antidiabetic Biguanides Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Antidiabetic Biguanides Capacity of Key Manufacturers in 2015
Figure China Antidiabetic Biguanides Capacity of Key Manufacturers in 2016
Table China Antidiabetic Biguanides Production of Key Manufacturers (2015 and 2016)
Table China Antidiabetic Biguanides Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic Biguanides Production Share by Manufacturers
Figure 2016 Antidiabetic Biguanides Production Share by Manufacturers
Table China Antidiabetic Biguanides Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Antidiabetic Biguanides Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antidiabetic Biguanides Revenue Share by Manufacturers
Table 2016 China Antidiabetic Biguanides Revenue Share by Manufacturers
Table China Market Antidiabetic Biguanides Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Antidiabetic Biguanides Average Price of Key Manufacturers in 2015
Table Manufacturers Antidiabetic Biguanides Manufacturing Base Distribution and Sales Area
Table Manufacturers Antidiabetic Biguanides Product Type
Figure Antidiabetic Biguanides Market Share of Top 3 Manufacturers
Figure Antidiabetic Biguanides Market Share of Top 5 Manufacturers
Table Anderson Hay & Grain Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Anderson Hay & Grain Inc. Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Anderson Hay & Grain Inc. Antidiabetic Biguanides Market Share (2011-2016)
Table Border Valley Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Border Valley Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Border Valley Antidiabetic Biguanides Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Antidiabetic Biguanides Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceuticals Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceuticals Antidiabetic Biguanides Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Antidiabetic Biguanides Market Share (2011-2016)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Antidiabetic Biguanides Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Antidiabetic Biguanides Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Antidiabetic Biguanides Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Antidiabetic Biguanides Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Antidiabetic Biguanides Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Antidiabetic Biguanides Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Antidiabetic Biguanides Capacity, Production and Growth (2011-2016)
Figure China Antidiabetic Biguanides Revenue (Million USD) and Growth (2011-2016)
Table China Antidiabetic Biguanides Production, Consumption, Export and Import (2011-2016)
Table China Antidiabetic Biguanides Production by Type (2011-2016)
Table China Antidiabetic Biguanides Production Share by Type (2011-2016)
Figure Production Market Share of Antidiabetic Biguanides by Type (2011-2016)
Figure 2015 Production Market Share of Antidiabetic Biguanides by Type
Table China Antidiabetic Biguanides Revenue by Type (2011-2016)
Table China Antidiabetic Biguanides Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Antidiabetic Biguanides by Type (2011-2016)
Figure 2015 Revenue Market Share of Antidiabetic Biguanides by Type
Table China Antidiabetic Biguanides Price by Type (2011-2016)
Figure China Antidiabetic Biguanides Production Growth by Type (2011-2016)
Table China Antidiabetic Biguanides Consumption by Application (2011-2016)
Table China Antidiabetic Biguanides Consumption Market Share by Application (2011-2016)
Figure China Antidiabetic Biguanides Consumption Market Share by Application in 2015
Table China Antidiabetic Biguanides Consumption Growth Rate by Application (2011-2016)
Figure China Antidiabetic Biguanides Consumption Growth Rate by Application (2011-2016)
Table China Antidiabetic Biguanides Production by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Production Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Production Value by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Sales Price by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Consumption by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic Biguanides Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Biguanides
Figure Manufacturing Process Analysis of Antidiabetic Biguanides
Figure Antidiabetic Biguanides Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Biguanides Major Manufacturers in 2015
Table Major Buyers of Antidiabetic Biguanides
Table Distributors/Traders List
Figure China Antidiabetic Biguanides Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Antidiabetic Biguanides Revenue and Growth Rate Forecast (2016-2021)
Table China Antidiabetic Biguanides Production, Import, Export and Consumption Forecast (2016-2021)
Table China Antidiabetic Biguanides Production Forecast by Type (2016-2021)
Table China Antidiabetic Biguanides Consumption Forecast by Application (2016-2021)
Table China Antidiabetic Biguanides Production Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetic Biguanides Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetic Biguanides Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)